XML 47 R52.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACQUISITIONS (Details) (EDT, USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended 12 Months Ended
Sep. 30, 2011
item
Mar. 31, 2012
Sep. 16, 2011
EDT
     
Acquisitions      
Cash paid for acquisition     $ 500,000,000
Ordinary shares issued as consideration in the acquisition 31.9    
Value of ordinary shares issued as consideration in the acquisition     525,100,000
Closing stock price (in dollars per share)     $ 16.46
Number of principal drug technology platforms 2    
Expenses related to acquisition   29,100,000  
Revenues from acquired business   165,000,000  
Net loss from acquired business   $ (6,300,000)